Berchem G - Search Results

1

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung.

Lazar V, Raynaud J, Magidi S, Bresson C, Martini JF, Galbraith S, Wunder F, Onn A, Batist G, Girard N, Lassen U, Pramesh CS, Al-Omari A, Ikeda S, Berchem G, Blay JY, Solomon B, Felip E, Tabernero J, Rubin E, Philip T, Porgador A, Berindan-Neagoe I, Schilsky RL, Kurzrock R. Lazar V, et al. Among authors: berchem g. Ther Adv Med Oncol. 2022 Oct 28;14:17588359221133893. doi: 10.1177/17588359221133893. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36324736 Free PMC article.

2

Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.

Pachchek S, Landoulsi Z, Pavelka L, Schulte C, Buena-Atienza E, Gross C, Hauser AK, Reddy Bobbili D, Casadei N, May P, Krüger R; NCER-PD Consortium. Pachchek S, et al. NPJ Parkinsons Dis. 2023 Dec 18;9(1):168. doi: 10.1038/s41531-023-00613-x. NPJ Parkinsons Dis. 2023. PMID: 38110362 Free PMC article. No abstract available.

3

Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy.

Pavelka L, Rauschenberger A, Hemedan A, Ostaszewski M, Glaab E, Krüger R; NCER-PD Consortium. Pavelka L, et al. Brain Commun. 2024 May 31;6(3):fcae187. doi: 10.1093/braincomms/fcae187. eCollection 2024. Brain Commun. 2024. PMID: 38863572 Free PMC article.

4

Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson's disease over seven years in a cohort: a comparative analysis.

Hanff AM, Krüger R, McCrum C, Ley C; NCER-PD. Hanff AM, et al. BMC Med Res Methodol. 2024 Aug 24;24(1):183. doi: 10.1186/s12874-024-02301-7. BMC Med Res Methodol. 2024. PMID: 39182059 Free PMC article.

5

Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.

Pachchek S, Landoulsi Z, Pavelka L, Schulte C, Buena-Atienza E, Gross C, Hauser AK, Reddy Bobbili D, Casadei N, May P, Krüger R; NCER-PD Consortium. Pachchek S, et al. NPJ Parkinsons Dis. 2023 Nov 23;9(1):156. doi: 10.1038/s41531-023-00595-w. NPJ Parkinsons Dis. 2023. PMID: 37996455 Free PMC article.

6

Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease.

Aho VTE, Klee M, Landoulsi Z, Heintz-Buschart A, Pavelka L, Leist AK, Krüger R, May P, Wilmes P; NCER-PD Consortium. Aho VTE, et al. NPJ Parkinsons Dis. 2024 Apr 6;10(1):78. doi: 10.1038/s41531-024-00687-1. NPJ Parkinsons Dis. 2024. PMID: 38582855 Free PMC article.

7

Comprehensive blood metabolomics profiling of Parkinson's disease reveals coordinated alterations in xanthine metabolism.

de Lope EG, Loo RTJ, Rauschenberger A, Ali M, Pavelka L, Marques TM, Gomes CPC, Krüger R, Glaab E; NCER-PD Consortium. de Lope EG, et al. NPJ Parkinsons Dis. 2024 Mar 19;10(1):68. doi: 10.1038/s41531-024-00671-9. NPJ Parkinsons Dis. 2024. PMID: 38503737 Free PMC article.

8

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.

Sosero YL, Bandres-Ciga S, Ferwerda B, Tocino MTP, Belloso DR, Gómez-Garre P, Faouzi J, Taba P, Pavelka L, Marques TM, Gomes CPC, Kolodkin A, May P, Milanowski LM, Wszolek ZK, Uitti RJ, Heutink P, van Hilten JJ, Simon DK, Eberly S, Alvarez I, Krohn L, Yu E, Freeman K, Rudakou U, Ruskey JA, Asayesh F, Menéndez-Gonzàlez M, Pastor P, Ross OA, Krüger R; NCER‐PD Consortium; Corvol JC, Koks S, Mir P, De Bie RMA, Iwaki H, Gan-Or Z; International Parkinson's Disease Genomic Consortium. Sosero YL, et al. Mov Disord. 2024 Oct;39(10):1773-1783. doi: 10.1002/mds.29960. Epub 2024 Aug 12. Mov Disord. 2024. PMID: 39132902

9

Impact of molecular diagnostics and targeted cancer therapy on patient outcomes (MODIFY): a retrospective study of the implementation of precision oncology.

Dang M, Schritz A, Goncharenko N, Berchem G. Dang M, et al. Among authors: berchem g. Mol Oncol. 2024 Dec 11. doi: 10.1002/1878-0261.13785. Online ahead of print. Mol Oncol. 2024. PMID: 39661533 Free article.

10

Real-world experience with isatuximab in the treatment of relapsed-refractory multiple myeloma: a case series from the Grand Duchy of Luxembourg.

De Wilde S, Plawny L, Berchem G. De Wilde S, et al. Among authors: berchem g. Hematology. 2023 Dec;28(1):2182098. doi: 10.1080/16078454.2023.2182098. Hematology. 2023. PMID: 36880781 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters